trending Market Intelligence /marketintelligence/en/news-insights/trending/gghxd0chgeuiejieuktjja2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Moody's places Express Scripts' ratings under review for downgrade

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Moody's places Express Scripts' ratings under review for downgrade

Moody's placed Express Scripts Holding Co.'s Baa2 senior unsecured debt under review for downgrade.

The rating agency placed the ratings under review with direction uncertain in March, after Cigna Corp. agreed to acquire Express Scripts for about $67 billion.

Moody's said the rating of the St. Louis, Mo.-based pharmacy benefit manager is unlikely to be upgraded, based on the progress to date in the rating review of Bloomfield, Conn.-based Cigna.

Express Scripts's Baa2 rating reflects its leading position in the market, moderate financial leverage and strong cash flow, according to Moody's.